The development of an effective vaccine against the new coronavirus is considered a priority in order to control the transmission and spread of the disease, however the side effects of these vaccines remain a concern that must be addressed. We report a case of pauci-immune glomerulonephritis with rapidly progressive deterioration of renal function, beginning a few days after the injection of the Adenovirus type 26 vaccine that encodes the SARS-CoV-2 spike glycoprotein * (Ad26. COV2-S) (Johnson & Johnson acute respiratory syndrome coronavirus 2 [SARS CoV-2] vaccine).
No takes yet. Share an insight, caveat, or question.
ALCALA et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: